BZYR - BURZYNSKI RESEARCH INSTITUTE INC
0.0203
-0.002 -11.823%
Share volume: 8,218
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.02
0.00
-0.11%
View ratios
| Fiscal Date | 05-31-2025 | 08-31-2025 | 11-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2026 | Q3 2026 | |
| Report Date | 07-15-2025 | 10-14-2025 | 01-13-2026 | |
| Assets | ||||
| Total Assets | 1.521 K | 1.331 K | 2.265 K | |
| Current Assets | 1.521 K | 1.331 K | 2.265 K | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 821.000 | 931.000 | 2.165 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 1.521 K | 1.331 K | 2.265 K | |
| Total liabilities | 71.237 K | 70.902 K | 69.608 K | |
| Total current liabilities | 71.237 K | 70.902 K | 69.608 K | |
| Accounts Payable | 25.682 K | 23.943 K | 45.101 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -69.716 K | -69.571 K | -67.343 K | |
| Common stock | 129.738 M | 130.072 M | 130.403 M | |
| Retained earnings | -129.808 M | -130.142 M | -130.471 M |